[Docidrazin. Long-term observation with a 3-component antihypertensive agent].
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001539:Bendroflumethiazide / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D004338:Drug Combinations; C037131:docidrazin; D006830:Hydralazine; D001539:Bendroflumethiazide; D011433:Propranolol
Docidrazin. Langzeitbeobachtung mit einem Drei-Komponenten-Antihypertonikum.